Central nervous system pharmacological effects of plants from northern Peruvian Andes: Valeriana adscendens, Iresine herbstii and Brugmansia arborea

Pharmaceutical Biology

Volumn 40, Issue 4, 2002, Pages 274-293

  Capasso, Anna ^a   De Feo, Vincenzo ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Brugmansia arborea; Central nervous system; Ethnopharmacology; Iresine herbstii; Morphine withdrawal; Psychotropic agents; Valeriana adscendens

Indexed keywords

4 AMINOBUTYRIC ACID; ALKALOID DERIVATIVE; AMINO ACID RECEPTOR AFFECTING AGENT; BRUGMANSIA ARBOREA EXTRACT; IRESINE HERBSTII EXTRACT; PLANT EXTRACT; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; VALERIANA ADSCENDENS EXTRACT;

4 AMINOBUTYRIC ACID UPTAKE; ARTICLE; BEHAVIOR; BRUGMANSIA ARBOREA; CATALEPSY; CENTRAL NERVOUS SYSTEM; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; GUINEA PIG; IN VITRO STUDY; IRESINE HERBSTII; LOCOMOTION; MALE; MEDICAL LITERATURE; MEDICINAL PLANT; MOTOR COORDINATION; MOUSE; NONHUMAN; SLEEP; STEREOTYPY; STIMULATION; SYNAPTOSOME; TRADITIONAL MEDICINE; VALERIANA ADSCENDENS;

AMARANTHACEAE; ANIMALIA; BRUGMANSIA; CAVIA PORCELLUS; DATURA ARBOREA; IRESINE; IRESINE HERBSTII; SOLANACEAE; SUS SCROFA; TRICHOCEREUS; VALERIANA; VALERIANACEAE;

EID: 0036405316     PISSN: 13880209     EISSN: None     Source Type: Journal    
DOI: 10.1076/phbi.40.4.274.8473     Document Type: Article

References (76)

1. Agurell S (1969): Cactaceae alkaloids. Lloydia 32: 206-216.
2. Allport NL (1943): The Chemistry and Pharmacy of Vegetable Drugs. London, George Newnes Limited, pp. 159-161.
3. Anaya Reyes-Gavilan H, Tacoronte Morales JE, Nogueiras Lima C, Fuentes Fiallo V, Basterrechea Rey M (1999): Determination of main alkaloids present in species of the Brug-mansiasection, gen. Datura Rev CENIC, Cienc Quim 30: 90-91, viaChem. Abs. 133: 307583, 2000.
4. Bhargava HN, Way EL (1972): Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice. J Pharmacol Exp Ther 183: 31-40.
5. Bianchi A, Samorini G (1993): Plants in Associacion with Ayahasuca. Jahrbuch Etnomedizin 1993: 21-42.
6. Bristol ML (1969): Tree Datura drugs of the Columbian Sibundoy. Bot Mus Leaf, Harvard Univ 22: 165-227.
7. Brown JH (1987): In: Gilman A, Goodman LS, Rall TW, Murad F, eds., The Pharmacological Basis of Therapeutics. New York, McMillan, pp. 150-165.
8. Bruneton J (1993): Pharmacognosie: Phytochimie Plantes Médicinales. Londres, TEC & DOC Lavoisier, pp. 481-485.
9. Cabieses Molina F (1990): The Magic Plants of the Ancient Perù. Atti del V Congresso Nazionale della Società Italiana di Fitochimica, LP2.
10. Capasso A, Di Giannuario A, Loizzo A, Pieretti S, Sorrentino L (1991a): Dexamethasone induced biphasic effects on morphine hypermotility in mice. Life Sci 49: 1411-1418.
11. Capasso A, Pinto A, Mascolo N, Autore G, Capasso F (1991b): Reduction of agonist-induced contractions of guinea-pig isolated ileum by flavonoids. Phytother Res 5: 85-87.
12. Capasso A, Di Giannuario A, Loizzo A, Pieretti S, Sorrentino L (1992): Central interaction of dexamethasone and RU-38486 on morphine antinociception in mice. Life Sci 52: PL 139-143.
13. Capasso A, De Feo V, De Simone F, Sorrentino L (1996a): Pharmacological effects of aqueous extract from Valeriana adscendens. Phytother Res 10: 309-312.
14. Capasso A, Di Giannuario A, Loizzo A, Pieretti S, Sagratella S, Sorrentino L (1996b): Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues. J Pharm Exp Ther 276: 743-751.
15. Capasso A, De Feo V, De Simone F, Sorrentino L (1997): Activity-directed isolation of spasmolytic (anti-cholinergic) alkaloids from Brugmansia arborea (L.) Lagerheim. Int J Pharmacog 35: 43-48.
16. Capasso A, De Feo V (2002): Alkaloids from Brugmansia arborea (L.) Lagerheim reduce morphine withdrawal in vitro. Phytother Res, in press.
17. Cavadas C, Araujo I, Cotrim MD, Amaral T, Cunha AP, Macedo T, Ribeiro CF (1995): In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on the GABA receptor in rat brain. Arzneimittelforschung 45: 753-755.
18. Chal LA (1983): Contracture of guinea-pig ileum on withdrawal of methionine3-enkephalin I is mediated by substance P. Br J Pharmacol 80: 741-749.
19. Collier HO, Cuthbert NJ, Francis DL (1981): Model of opiate dependence in the guinea-pig isolated ileum. Br J Pharmacol 73: 921-932.
20. Cruz-Sanchez G (1948): Informe sobre las aplicaciones populares de la cimora en el norte del Perú. Rev Farm Med Exp (Lima) 1: 253-258.
21. De Feo V (1992): Medicinal and magical plants on northern Peruvian Andes. Fitoterapia 63: 417-440.
22. De Feo V, Capasso A, De Simone F, Sorrentino L (1996): CNS Pharmacological activity of aqueous extract of Iresine herbstii. Int J Pharmacog 34: 184-188.
23. De Feo V, Faro C (2002): Pharmacological effects of extracts from Valeriana adscendens Trel. II. Effects on GABA uptake and amino acids. Phytother Res, in press.
24. Diaz JL (1979): Ethnopharmacology and ethnopharmacognosy of Mexican psychodysleptic plants. J Psyched Drugs 11: 71-101.
25. Dobkin De Rios M (1977): Plant hallucinogens and the religion of the Mochica - An ancient Peruvian people. Econ Bot 31: 189-203.
26. Dunaev VV, Trzhetsinskii SD, Tishkin VS, Fursa NS, Linenko VI (1987): Biological activity of the sum of valepotriates isolated from Valeriana alliariifolia. Farmakol Toksikol 50: 33-37.
27. Evans WC (1979): Tropane alkaloids in Solanaceae. In: Hawkes JG, Lester RN, Shelding AD, eds., The Biology and Taxonomy of Solanaceae. London, Academic Press, pp. 245-254.
28. Fog R (1972): On the stereotypy and catalepsy: Studies on the effects of amphetamine and neuroleptics in rats. Acta Neurol Scand 50 (suppl.): 3-66.
29. Friedberg C (1959): Rapport sommaire d'une mission au Pérou. J Agric Trop Bot Appl 6: 439-450.
30. Gambaro VE, Roses OE (1989): La presencia de nicotina en extractos y decocciones de flores deBrugmansia candida Pers. Acta Farm Bonaerense 8: 17-22.
31. Ghani A (1985): Cuscohygrine from some solanaceous plants. Indian J Pharm Sci 47: 127-129.
32. Griffin WJ, Lin DG (2000): Chemotaxonomy and geographical distribution of tropane alkaloids. Phytochemistry 53: 623-637.
33. Hajos F (1975): An improved method for the preparation of synaptosomal fractions in high purity. Brain Res 95: 485-489.
34. Hecht A, Schiorring E (1979): Behavioral effects of low and high acute doses of morphine in solitary mice. Psychopharmacology 64: 73-79.
35. Houghton PJ (1999): The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol 51: 505-512.
36. Hunziker TA (1979): South-American Solanaceae: A synoptic survey. In Hawkes JG, Lester RN, Shelding AD, eds., The Biology and Taxonomy of Solanaceae. London, Academic Press, pp. 49-85.
37. Jaffe JH (1990): Drug addiction and drug abuse. In: Gilman A, Goodman LS, Rall TW, Murad F, eds., The Pharmacological Basis of Therapeutics. (8th edn.). New York, McMillan, pp. 553-573.
38. Johnson SM, Westfall DP, Howard SA, Fleming WW (1988): Sensitivies of the isolated ileal longitudinal smooth muscle-myenteric plexus and hypogastric nerve vas deference of the guinea-pig after chronic morphine. J Pharm Exp Ther 204: 54-66.
39. Kiritsy-Roy JA, Standish SM, Terry LC (1989): Dopamine D1 and D2 receptor agonists potentiate analgesic and motor effects of morphine. Pharmacol Biochem Behav 32: 717-721.
40. Leathwood PD, Chauffard F, Heck E, Munoz-Box R (1982): Aqueous extract of valerian (Valeriana officinalis) improves sleep quality in man. Pharmacol Biochem Behav 17: 65-72.
41. Leathwood PD, Chauffard F (1985): Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med 51: 144-147.
42. Leuschner J, Müller J, Rudmann M (1993): Characterization of central nervous depressant activity of commercially available valerian root extract. Arzneimittelforschung 43: 638-641.
43. Lockwood TE (1979): The ethnobotany of Brugmansia. J Ethnopharmacol 1: 147-164.
44. B (antagonist,) prevents antinociception and muscle-relaxant effect induced by bactofen. Br J Pharmacol 103: 1303-1308.
45. Marfori P (1941): Trattato di Farmacologia e Terapia. Casa Editrice Libraria V. Napoli, Idelson.
46. Marfori P (1941): Trattato di Farmacologia e Terapia. Casa Editrice Libraria V. Napoli, Idelson. Martin WR, Eades CG (1967): Demonstration of tolerance and physical dependence in dog following a short-term infusion of morphine. Psychopharmacologia 11: 195-223.
47. McKenna DJ, Luna LE, Towers CHN (1986): Ingredientes biodinamicos en las plantas que se mezclan al ayahusca. Una farmacopea tradicional no identificada. America Indigena 46: 73-98.
48. McLaughlin JL (1973): Peyote: An introduction. Lloydia 36: 1-8.
49. Mendelsohn E, Balick MJ (1995): The value of undiscovered pharmaceuticals in tropical forests. Econ Bot 49: 223-228.
50. Okpako DT, Taiwo YOO (1984): Cyclo-oxygenase inhibitors antagonize indirectly evoked contractions of guinea-pig isolated ileum by inhibiting acetylcholine release. Br J Pharmacol 82: 577-585.
51. 3H]GABA release. Neurochem Res 24: 1373-1378.
52. Pieretti S, Capasso A, Di Giannuario A, Loizzo A, Sorrentino L (1991): The interaction of peripherally and centrally administered dexamethasone and RU-38486 on morphine analgesia in mice. Gen Pharmacol 22: 829-833.
53. Pieretti S, Di Giannuario A, Capasso A, Nicoletti M (1992): Pharmacological effects of phenylpropanoid glycosides from Orobanche hederae. Phytother Res 6: 89-93.
54. Pieretti S, Di Giannuario A, Capasso A, Sorrentino L, Loizzo A (1994): Effects induced by cisteamine on chemically-induced nociception in mice. Life Sci 54: 1091-1099.
55. Poisson J (1960): The presence of mescaline in a Peruvian cactus. Ann Pharm Fr 18: 764-765.
56. Polia M (1988): Las Lagunas de los Encantos - Medicina Tradicional Andina en el Peru septentrional. Lima, CePeSer.
57. Rivier L, Lindgren JE (1972): Ayahuasca: The South American hallucinogenic drink: An ethnobotanical and chemical investigation. Econ Bot 26: 101-129.
58. Roses OE, Lopez CM, Garcia Fernandez JC (1987): Aislamiento e identificación de alcaloides del tropano en especies del género Brugmansia (Solanaceae). Acta Farm Bonaerense 6: 167-174.
59. Roses OC, Villaamii EE, Garcia Fernandez JC, Miño JH (1988a): Accion farmacodinamica de las flores de la Brugmansia candida. Fitoterapia 59: 120-125.
60. Roses OE, Gambaro VE, Rofi R (1988b): La presencia de norhioscina y hioscina en flores de Brugmansia candida Pers. como posible caracteristica de su procedencia. Acta Farm Bonaerense 7: 85-90.
61. Santos MS, Ferreira F, Cunha AP, Carvalho AP, Macedo T (1994a): Aqueous extract of Valerian influences the transport of GABA in synaptosomes. Planta Med 60: 278-279.
62. 3H]GABA release in synaptosomes. Planta Med 60: 475-476.
63. Santos MS, Ferreira F, Cunha AP, Carvalho AP, Ribeiro CF, Macedo T (1994c): Synaptosomal GABA release as influenced by Valerian root extract. Involvement of the GABA carrier. Arch Int Pharmacodyn Thér 327: 220-231.
64. Sarazin C, Goethals G, Séguin JP, Barbotin JN (1991): Spectral reassignment and structure elucidation of scopolamine free base through two-dimensional NMR techniques. J Magn Res Chem 29: 291-300.
65. Schultes RE (1955): A new narcotic genus from the Amazon slope in the Colombian Andes. Bot Mus Leaf, Harvard Univ 17: 1-11.
66. Schultes RE (1979): Solanaceous hallucinogens and their role in the development of the new world cultures. In: Hawkes JG, Lester RN, Shelding AD, eds., The Biology and Taxonomy of Solanaceae. London, Academic Press, pp. 137-160.
67. Schultes RE (1991): The reason for ethnobotanical conservation. In: Akerele O, Heywood VH, Synge H, eds., Conservation of Medicinal Plants. Cambridge, Cambridge Press, pp. 65-75.
68. Schultes RE, Hoffman A (1973): The Botany and Chemistry of Hallucinogens. Springfield, C. C. Thomas.
69. Shulgin AT (1979): Chemistry of phenethylamines related to mescaline. J Psyched Drugs 11: 41-52.
70. Smith TA (1977): Phenethylamine and related compounds in plants. Phytochemistry 16: 9-18.
71. Speroni E, Minghetti A (1988): Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med 54: 488-491.
72. Stenberg VI, Narain NK, Singh P (1977): Carbon-13 magnetic resonance of the tropane alkaloids: Cocaine and atropine. J Heterocyclic Chem 14: 225-226.
73. Taddei I, Giacchetti D (1980): Fondamenti di Farmacognosia. Bologna, Editoriale Grasso.
74. Tallarida RJ, Murray RB (1987): Manual of Pharmacologic Calculation with Computer Programs (2nd edn). Berlin, Springer Verlag.
75. Tsou K, Lovie G, Way EL (1982): Manifestation of gut opiate withdrawal contracture and its blockade by capsaicin. J Antibiot 81: 377-383.
76. Zamora-Martinez MC, Nieto de Pascual Pola C (1992): Medicinal plants used in some rural populations in Oaxaca, Puebla and Veracruz, Mexico. J Ethnopharmacol 35: 229-257.